FDA Calendar

March 27-April 2, Keystone, Colo.

HIV PATHOGENESIS MEETING

Includes presentation from Adventrx Pharmaceuticals Inc. On antiviral compound Thiovir and oncology compound ANX-530 (vinorelbine emulsion)

March 29-30, Cambridge, Mass.

IBC THIRD ANNUAL OCULAR ANTI-ANGIOGENESIS CONFERENCE

Includes presentation from Genaera Corp. on phase 2 clinical trials of Evison for age-related macular degeneration

April 1-5, Washington

2006 AMERICAN ASSOCIATION FOR CANCER RESEARCH ANNUAL MEETING

Includes presentations from Ariad Pharmaceuticals Inc. on development pipeline, Src for ovarian carcinoma and AP23573 for soft-tissue and bone sarcomas; presentation from Chemokine Therapeutics Corp. on preclinical study of CTCR-9908 anticancer compound in prostate cancer model; presentation from Rigel Pharmaceuticals Inc. on Axl kinase for angiogenesis and tumor growth; presentation from Cytogen Corp. on Quadramet for multiple myeloma; presentation from AEterna Zentaris Inc. on new cytotoxic compound with inhibitory effects on tubulin polymerization and Topoisomerase II as related to ZEN-012/ZEN-017 for breast, colon and skin cancer; presentation from Halozyme Therapeutics Inc. on phase 1 Chemophase clinical trial for bladder cancer and presentation from Oncolytics Biotech Inc. on phase 1 combination Reolysin/radiation clinical trial results

April 1-8, San Diego

58th AMERICAN ACADEMY OF NEUROLOGY ANNUAL MEETING

Includes presentation from CepTor Corp. on abstract for Myodur calpain inhibitor for Duchenne Muscular Dystrophy

April 4-5, New York

CIBC WORLD MARKETS ANNUAL BIOTECHNOLOGY & SPECIALTY PHARMACEUTICALS CONFERENCE

Includes presentation from DOV Pharmaceutical Inc. on Bicifadine as analgesic in animal models of neuropathic pain and data from phase 3 trial results

April 6-8, Mannheim, Germany

EORTC SOFT TISSUE AND BONE SARCOMA GROUP MEETING

Includes presentation from Ariad Pharmaceuticals Inc. on development pipeline and AP23573 for soft-tissue and bone sarcomas

April 7, Bethesda, Md.

ALLERGENIC PRODUCTS ADVISORY COMMITTEE MEETING (FDA)

Includes discussion on proposed strategy for reclassification of class IIIA allergenic products, update of the FDA critical path initiative

April 11-13, Gaithersburg, Md.

GENERAL AND PLASTIC SURGERY DEVICES PANEL OF THE MEDICAL DEVICES ADVISORY COMMITTEE (FDA)

Includes oral presentations from public, discussion, recommendations and vote on two premarket approval applications for silicone gel-filled breast prostheses

April 15, Rockville, Md.

SCIENCE BOARD TO THE FOOD AND DRUG ADMINISTRATION MEETING

Discussion and presentation on agency's pre- and post-marketing safety programs for drugs and biologics and good manufacturing practices for vaccines, blood and cell, tissue and gene products

April 19-22, Geneva, Switzerland

9th INTERNATIONAL GENEVA/SPRINGFIELD SYMPOSIUM ON ADVANCES IN ALZHEIMER THERAPY

Includes presentations from Axonyx Inc. on Phenserine and Posiphen

April 22, Gaithersburg, Md.

CIRCULATORY SYSTEM DEVICES PANEL OF THE MEDICAL DEVICES ADVISORY COMMITTEE (FDA)

Includes presentation by the Office of Surveillance and Biometrics on its review of post-market study design, update on recently purchased devices, recommendations on premarket notification submission for coronary proximal anastomosis device

April 24-25, New York

UBS GLOBAL PHARMACEUTICALS CONFERENCE

Includes presentation from DOV Pharmaceutical Inc. on Bicifadine as analgesic in animal models of neuropathic pain and data from phase 3 trial results

April 26-30, Vienna, Austria

41st ANNUAL MEETING OF THE EUROPEAN ASSOCIATION FOR THE STUDY OF THE LIVER

Includes presentation from Idenix Pharmaceuticals Inc. on 13 abstracts, including Valopicitabine, and other presentations on liver transplantation, cirrhosis, tumors and viral hepatitis

April 27-29, Denver

AMERICAN HEART ASSOCIATION'S 7th ANNUAL CONFERENCE ON ARTERIOSCLEROSIS

Includes presentation from PreMD Inc. on Prevu Point of Care Skin Sterol Test, a cardiovascular product

May 3-6, San Antonio

AMERICAN PAIN SOCIETY'S 25th ANNUAL SCIENTIFIC MEETING

Includes presentation from DOV Pharmaceutical Inc. on Bicifadine as analgesic in animal models of neuropathic pain and data from phase 3 trial results

May 7-11, San Juan, Puerto Rico

19th INTERNATIONAL CONFERENCE ON ANTIVIRAL RESEARCH

Includes presentations on antiviral drug and antiviral chemotherapy research

May 15-20, Toronto

ANNUAL MEETING OF THE AMERICAN PSYCHIATRIC ASSOCIATION

Includes presentation from Nymox Pharmaceutical Corp. on AlzheimAlert, a urine-based diagnostic aid, and its successful clinical studies

May 17, Gaithersburg, Md.

PERIPHERAL AND CENTRAL NERVOUS SYSTEM DRUGS ADVISORY COMMITTEE MEETING (FDA)

Includes discussion on Novartis Pharmaceuticals Corp.'s supplemental New Drug Application 20823, SE1-016, Exelon capsules for mild to moderate dementia associated with Parkinson's disease

May 17-18, Baltimore

INDUSTRY EXCHANGE WORKSHOP ON FOOD AND DRUG ADMINISTRATION CLINICAL TRIAL REQUIREMENTS

Public workshop in cooperation with the Society of Clinical Research Associates on FDA clinical trial statutory and regulatory requirements

May 20-25, Los Angeles

DIGESTIVE DISEASE WEEK CONFERENCE

Includes presentation from Callisto Pharmaceuticals Inc. on Guanilib for gastrointestinal inflammation and presentation from Cytogen Corp. on Prostascint, a diagnostic imaging agent for newly diagnosed patients with biopsy-proven prostate cancer

May 31-June 3, Scottsdale, Ariz.

20th CONSORTIUM OF MULTIPLE SCLEROSIS CENTERS' ANNUAL MEETING

Includes presentation from PharmaFrontiers Corp. on study of patients treated with monovalent T cell therapy

June 2-6, Atlanta

2006 AMERICAN SOCIETY OF CLINICAL ONCOLOGY ANNUAL MEETING

Includes presentation from Oncolytics Biotech Inc. on Reolysin clinical trial data, Bioenvision Inc. on Evoltra for adult acute myeloid leukemia; presentation from Cytogen Corp. on Quadramet for multiple myeloma and Cell Genesys Inc. on trial of GM-CSF-gene transduced allogeneic prostate cancer cellular immunotherapy with human anti-CTLA-4 antibody for hormone-refractory prostate cancer and K562/GM-CSF vaccination for tumor burden related to chronic myelogenous leukemia

July 12-15, Washington

13th WORLD CONFERENCE ON TOBACCO OR HEALTH

Includes presentation from Nymox Pharmaceutical Corp. on results for saliva NicAlert test for tobacco exposure

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.